In silico strategies for probing novel DPP-IV inhibitors as anti-diabetic agents

References

• Baell, J. B., & Holloway, G. A. (2010). New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. Journal of Medicinal Chemistry, 53(7), 2719–2740. 10.1021/jm901137j
   PubMed Web of Science ®Google Scholar
• Brough, P. A., Aherne, W., Barril, X., Borgognoni, J., Boxall, K., Cansfield, J. E., Cheung, K. M. J., Collins, I., Davies, N. G. M., Drysdale, M. J., Dymock, B., Eccles, S. A., Finch, H., Fink, A., Hayes, A., Howes, R., Hubbard, R. E., James, K., Jordan, A. M., … Wright, L. (2008). 4, 5-Diarylisoxazole Hsp90 Chaperone inhibitors: Potential therapeutic agents for the treatment of cancer. Journal of Medicinal Chemistry, 51(2), 196–218. 10.1021/jm701018h
   PubMed Web of Science ®Google Scholar
• Choy, M., & Lam, S. (2007). Sitagliptin: A novel drug for the treatment of type 2 diabetes. Cardiology in Review, 15(5), 264–271.
   PubMedGoogle Scholar
• Degtyarenko, K., de Matos, P., Ennis, M., Hastings, J., Zbinden, M., McNaught, A., Alcántara, R., Darsow, M., Guedj, M., & Ashburner, M. (2007). ChEBI: A database and ontology for chemical entities of biological interest. Nucleic Acids Research, 36(Database), D344–D350. 10.1093/nar/gkm/791
   PubMed Web of Science ®Google Scholar
• dos Santos, J. L., & Chin, C. M. (2015). Pan-Assay Interference Compounds (PAINS): warning signs in biochemical-pharmacological evaluations. Biochemistry & Pharmacology, 4, e173–e174. 10.4172/2167-0501.1000e173
   Google Scholar
• Ertl, P., & Schuffenhauer, A. (2009). Estimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributions. Journal of Cheminformatics, 1(1), 8–17. 10.1186/1758-2946-1-8
   PubMed Web of Science ®Google Scholar
• Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., & Overington, J. P. (2012). ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Research, 40(D1), D1100–D1107. 10.1093/nar/gkr777
   PubMed Web of Science ®Google Scholar
• Ghatak, S. B., Patel, D. S., Shanker, N., Srivastava, A., Deshpande, S. S., & Panchal, S. J. (2011). Linagliptin: A novel xanthine-based dipeptidyl peptidase-4 inhibitor for treatment of type II diabetes mellitus. Current Diabetes Reviews, 7(5), 325–335. 10.2174/157339911797415648
   PubMedGoogle Scholar
• GLIDE. (2009). version 5.0. Schro ¨dinger Inc.
   Google Scholar
• Guardiola, S., Prades, R., Mendieta, L., Brouwer, A. J., Streefkerk, J., Nevola, L., Tarragó, T., Liskamp, R. M. J., & Giralt, E. (2018). Targeted covalent inhibition of prolyloligopeptidase (POP): Discovery of sulfonylfluoride peptidomimetics. Cell Chemical Biology, 25(8), 1031–1037. 10.1016/j.chembiol.2018.04.013
   PubMed Web of Science ®Google Scholar
• Haffner, C. D., Diaz, C. J., Miller, A. B., Reid, R. A., Madauss, K. P., Hassell, A., Hanlon, M. H., Porter, D. J., Becherer, J. D., & Carter, L. H. (2008). Pyrrolidinylpyridone and pyrazinone analogues as potent inhibitors of prolyloligopeptidase (POP). Bioorganic & Medicinal Chemistry Letters, 18(15), 4360–4363. 10.1016/j.bmcl.2008.06.067
   PubMed Web of Science ®Google Scholar
• Karuranga, S., Fernandes, J. R., Huang, Y., Malanda, B. (2017).. International Diabetes Federation- IDF Diabetes Atlas (8th ed.). International Diabetes Federation.
   Google Scholar
• Ioakimidis, L., Thoukydidis, L., Mirza, A., Naeem, S., & Reynisson, J. (2008). Benchmarking the reliability of QikProp. Correlation between experimental and predicted values. QSAR & Combinatorial Science, 27(4), 445–456. 10.1002/qsar.200730051
   Google Scholar
• Kimata, H., Fukuda-Tusura, S., Yoshida, K., Iwasaki, S., Kiuchi, S., Akahoshi, F., & Ishii, S. (2012). Teneligliptin, a novel selective Dipeptidyl peptidase IV inhibitor, improves prostprandial hyperglycaemia in a model of type 2 diabetes, zucker diabetic fatty rats. Medical Consultation and New Remedies, 49, 9.
   Google Scholar
• Kochev, N., Avramova, S., Angelov, P., & Jeliazkova, N. (2018). Computational prediction of synthetic accessibility of organic molecules with Ambit-synthetic accessibility tool. Organic Chemistry: An Indian Journal, 14, 123.
   Google Scholar
• Lagorce, D., Sperandio, O., Baell, J. B., Miteva, M. A., & Villoutreix, B. O. (2015). FAF-Drugs3: A web server for compound property calculation and chemical library design. Nucleic Acids Research, 43(W1), W200–W207. 10.1093/nar/gkv353
   PubMed Web of Science ®Google Scholar
• Malik, R., Choudhary, B. S., Srivastava, S., Mehta, P., & Sharma, M. (2017). Identification of novel acetylcholinesterase inhibitors through e-pharmacophore-based virtual screening and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 35(15), 3268–3284. 10.1080/07391102.2016.1253503
   PubMed Web of Science ®Google Scholar
• Mehta, P., & Malik, R. (2019). Discovery and identification of putative Adenosine Kinase inhibitors as potential anti-epileptic agents from structural insights. Journal of Biomolecular Structure and Dynamics, 9, 1–18. 10.1080/07391102.2019.1699447
   Web of Science ®Google Scholar
• Nabeno, M., Akahoshi, F., Kishida, H., Miyaguchi, I., Tanaka, Y., Ishii, S., & Kadowaki, T. A. (2013). Comparative study of the binding modes of recently launched Dipeptidyl peptidase IV inhibitors in the active pocket. Biochemical and Biophysical Research Communications, 434(2), 191–196. 10.1016/j.bbrc.2013.03.010
   PubMed Web of Science ®Google Scholar
• Nath, V., Agrawal, R., & Kumar, V. (2020). Structure based docking and molecular dynamics studies: Peroxisome proliferator-activated receptors –α/γ dual agonists for treatment of metabolic disorders. Journal of Biomolecular Structure and Dynamics, 38(2), 511–523. 10.1080/07391102.2019.1581089
   PubMed Web of Science ®Google Scholar
• Sharma, J., Yadav, D., & Paliwal, S. (2013). Discovery of novel DPP IV inhibitors: Application of pharmacophore-based virtual screening. Medicinal Chemistry Research, 22(2), 558–572. 10.1007/s00044-012-0044-8
   Web of Science ®Google Scholar
• Sharma, S., Paliwal, S., Singh, S., & Akhter, M. (2016). Molecular modelling of viral nucleocapsid protein zinc fingers modulators. Indian Journal of Biochemistry and Biophysics, 53, 24–38. http://nopr.niscair.res.in/handle/123456789/42336
   Web of Science ®Google Scholar
• Sharma, S., Srivastava, S., Shrivastava, A., Malik, R., Almalki, F., Saifullah, K., Alam, M. M., Shaqiquzzaman, M., Shakir Ali, S., & Akhter, M. (2019). Mining of potential dipeptidyl peptidase-IV inhibitors as anti-diabetic agents using integrated in silico approaches. Journal of Bimolecular Structure and Dynamics, 18, 1 -13 10.1080/07391102.2019.1701553
   Web of Science ®Google Scholar
• Sperandio, O., Miteva, M., & Villoutreix, B. O. (2008). Combining ligand and structure based methods in drug design projects. Current Computer Aided-Drug Design, 4(3), 250–258. 10.2174/157340908785747447
   Web of Science ®Google Scholar
• Srivastava, S., Choudhary, B. S., Mehta, P., Sukanya, Sharma, M., & Malik, R. R. (2019). Molecular dynamics insights for PI3K-δ inhibition & structure guided identification of novel PI3K-δ inhibitors. Journal of Biomolecular Structure and Dynamics, 37, 2404–2414. 10.1080/07391102.2018.1489304
   PubMed Web of Science ®Google Scholar
• Tarragó, T., Masdeu, C., Gómez, E., Isambert, N., Lavilla, R., & Giralt, E. (2008). Benzimidazolium salts as small, nonpeptidic and BBB-permeable human prolyloligopeptidase inhibitors. ChemMedChem, 3(10), 1558–1565. 10.1002/cmdc.200800152
   PubMed Web of Science ®Google Scholar
• Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W., & Taylor, R. D. (2003). Improved protein-ligand docking using GOLD. Proteins: Structure, Function, and Bioinformatics, 52(4), 609–623. 10.1002/prot.10465
   PubMed Web of Science ®Google Scholar
• Wilson, G. L., & Lill, M. A. (2011). Integrating structure-based and ligand-based approaches for computational drug design. Future Medicinal Chemistry, 3(6), 735–750. 10.4155/fmc.11.18
   PubMed Web of Science ®Google Scholar